Abstract
The tyrosine kinase inhibitor sunitinib is used for the treatment of numerous cancers in humans. In diabetic patients, sunitinib lowers blood glucose ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
